Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Early antigen titers in pediatric patients with acute cervical lymphadenitis.

Boyd EL, McClung JE, Veltri RW, Sprinkle PM.

Otolaryngol Head Neck Surg. 1982 Jan-Feb;90(1):6-10.

PMID:
6283458
2.
3.
4.

Antibodies to Epstein-Barr virus-specific antigens in patients with hairy-cell leukemia.

Sakamoto K, Aiba M, Katayama I, Sullivan JL, Humphreys RE, Purtilo DT.

Int J Cancer. 1981;27(4):453-8.

PMID:
6268553
5.

Antibodies to the Epstein-Barr virus transactivator protein (ZEBRA) as a valuable biomarker in young patients with nasopharyngeal carcinoma.

Dardari R, Khyatti M, Benider A, Jouhadi H, Kahlain A, Cochet C, Mansouri A, El Gueddari B, Benslimane A, Joab I.

Int J Cancer. 2000 Apr 1;86(1):71-5.

6.

Decreased antibody reactivity to Epstein-Barr virus capsid antigen in type 1 (insulin-dependent) diabetes mellitus.

Hyöty H, Räsänen L, Hiltunen M, Lehtinen M, Huupponen T, Leinikki P.

APMIS. 1991 Apr;99(4):359-63.

PMID:
1645169
9.

Subclass reactivity to Epstein-Barr virus capsid antigen in primary and reactivated EBV infections.

Linde A, Andersson J, Lundgren G, Wahren B.

J Med Virol. 1987 Feb;21(2):109-21.

PMID:
3029317
10.

Real-time Epstein-Barr virus PCR for the diagnosis of primary EBV infections and EBV reactivation.

Luderer R, Kok M, Niesters HG, Schuurman R, de Weerdt O, Thijsen SF.

Mol Diagn. 2005;9(4):195-200.

PMID:
16392898
11.

High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis.

Touge C, Agawa H, Sairenji T, Inoue Y.

Arch Virol. 2006 May;151(5):895-903. Epub 2005 Dec 16.

PMID:
16362642
12.

Evaluation of a semi-quantitative ELISA for IgA antibody against Epstein-Barr virus capsid antigen in the serological diagnosis of nasopharyngeal carcinoma.

Chen H, Chi P, Wang W, Li L, Luo Y, Fu J, Zhang L, Liu W.

Int J Infect Dis. 2014 Aug;25:110-5. doi: 10.1016/j.ijid.2014.03.1373. Epub 2014 May 27.

13.

Serological diagnosis of Epstein-Barr virus infection by novel ELISAs based on recombinant capsid antigens p23 and p18.

Färber I, Hinderer W, Rothe M, Lang D, Sonneborn HH, Wutzler P.

J Med Virol. 2001 Apr;63(4):271-6.

PMID:
11241457
14.
15.

Significance of specific Epstein-Barr virus IgA and elevated IgG antibodies to viral capsid antigens in nasopharyngeal carcinoma patients.

Hadar T, Rahima M, Kahan E, Sidi J, Rakowsky E, Sarov B, Sarov I.

J Med Virol. 1986 Dec;20(4):329-39.

PMID:
3025351
16.

Antibodies to Epstein-Barr virus in patients with nasopharyngeal carcinoma and in comparison groups.

Neel HB 3rd, Pearson GR, Taylor WF.

Ann Otol Rhinol Laryngol. 1984 Sep-Oct;93(5 Pt 1):477-82.

PMID:
6093669
17.

[Evaluation of IgG and IgA type antibodies to capsid and early antigens of the Epstein-Barr virus in the diagnosis of nasopharyngeal carcinoma].

Mendoza J, Rojas A, de la Rosa M, Amador JM, Expósito J, Esquivias J.

Med Clin (Barc). 1991 Nov 9;97(16):609-11. Spanish.

PMID:
1662737
18.

Epstein-Barr virus infections in childhood.

Oberender H, Graessner U, Falkenhagen U, Kunkel M, Gärtner L, Kupatz H, Schumacher K.

Acta Virol. 1979 Mar;23(2):137-42.

PMID:
39436
19.

False positivity of IGM antibody to Epstein-Barr viral capsid antigen during acute hepatitis A infection.

Fikar CR, McKee C.

Pediatr Infect Dis J. 1994 May;13(5):413-4. No abstract available.

PMID:
8072826
20.

[Epstein-Barr virus and infectious mononucleosis. A clinical study of Epstein-Barr antibodies (author's transl)].

Seigneurin JM, Kressmann MC, Lavoué MF, Saez G, Lenoir G.

Nouv Presse Med. 1978 Dec 9;7(44):4005-10. French.

PMID:
215969

Supplemental Content

Support Center